MedicalResearch.com |

22 Apr Understanding Panic Disorder

Posted at 19:49h in Mental Health Research

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact...

“Blood Pressure” by Bernard Goldbach is licensed under CC BY 2.0

11 Apr Hypertension: Personalized Treatment May Reduce Need for Higher Doses and Multiple Medications

Posted at 21:19h in Author Interviews, Blood Pressure - Hypertension, Personalized Medicine

MedicalResearch.com Interview with: Johan Sundström, MD, PhD Professor of Epidemiology at Uppsala University Professorial Fellow at The George Institute for...

. Prostate After Treatment.jpg: Over time, the body’s natural healing response removes the dead cells, shrinking the prostate. With the extra tissue removed, the urethra opens, reducing BPH symptoms. Most patients begin to experience symptom relief in as soon as two weeks and maximum benefit will occur in about three months.

05 Apr Prostate Cancer: 15 Year Follow Up Compares Treatment with Surgery, Radiation and Active Surveillance

Posted at 18:44h in Author Interviews, Prostate Cancer

MedicalResearch.com Interview with: Freddie C. Hamdy FRCS, FMedSci Nuffield Professor of Surgery, University of Oxford Jenny L. Donovan PhD, FMedSci...

Alexia Aguilar Geisinger Commonwealth School of Medicine Scranton, PA

05 Mar Ten states including New York and Texas Prescribed no Esketamine or Ketamine to Medicaid patients

Posted at 12:58h in Author Interviews, Depression

Editor’s note: This piece discusses suicide. If you have experienced suicidal thoughts or have lost someone to suicide and want...

Shinobu Itagaki, MD, MSc Assistant Professor Cardiovascular Surgery Icahn School of Medicine at Mount Sinai, New York, NY

21 Feb Benefits and Drawbacks of Simultaneous Heart Kidney Transplantation

Posted at 11:09h in Author Interviews, Heart Disease, JACC, Kidney Disease, Transplantation

MedicalResearch.com Interview with: Shinobu Itagaki, MD, MSc Assistant Professor Cardiovascular Surgery Icahn School of Medicine at Mount Sinai, New York,...

“Elliptical Stationary Bikes GVSU Winter Hall Exercise Center 2-4-15” by Steven Depolo is licensed under CC BY 2.0

03 Feb Study Evaluates High vs Low Intensity Exercise for Knee Arthritis

Posted at 15:05h in Author Interviews

Our study was designed as a superior trial, meaning that even though we failed to show that high-dose treatment is better than low-dose treatment, our results do not imply that a low-dose exercise regimen is as beneficial as a high-dose regimen.

“cocaine photo” by Imagens Evangélicas is licensed under CC BY 2.0

02 Feb Managing Cocaine Withdrawal Symptoms

Posted at 11:36h in Addiction, Cocaine

Don't wait any longer - contact SAMHSA today for more information about getting help for your cocaine addiction!

28 Jan PPIs Linked to Increased Risk of Heart Disease and Death in Type 2 Diabetes

Posted at 13:59h in Author Interviews, Diabetes, JCEM, Pharmacology

These findings suggest that the clinical benefits of proton pump inhibitors use against the excess risks of cardiovascular events and mortality should be taken into consideration among patients with type 2 diabetes.

18 Jan Specific Probiotic Dramatically Decreases Staph Aureus in the Gut

Posted at 17:11h in Author Interviews, Lancet, MRSA, NIH

Patients that we are thinking of who could benefit from this approach include those with increased S. aureus infection risk in long-term care facilities or chronic and recurring S. aureus infections.

21 Dec The Latest Trends in Psoriasis Research

Posted at 16:39h in Author Interviews, Dermatology

Autoimmune skin conditions like Psoriasis can lead to a lifetime of problems. Treatments are one of the many steps professionals take to reduce the symptoms.

Nathalie Franchimont, M.D., Ph.D. Senior Vice President, Head of Multiple Sclerosis and Immunology Head of the Multiple Sclerosis and Immunology Development Unit Biogen

15 Sep BIOGEN: Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus

Posted at 23:31h in Author Interviews, Biogen, NEJM, Rheumatology

Lupus is a chronic autoimmune disease that disproportionately affects women and people of color who have historically been underserved in medicine and face greater challenges accessing care. There is currently no cure.

Raymond H. Mak, MD Radiation Oncology Disease Center Leader for Thoracic Oncology Director of Patient Safety and QualityDirector of Clinical Innovation Associate Professor, Harvard Medical School Cancer - Radiation Oncology, Radiation Oncology Department of Radiation Oncology Brigham and Women's Hospital

07 Sep Lung Cancer: Human-AI Collaboration Can Accelerate Time to Treatment

Posted at 13:27h in Author Interviews, Brigham & Women's - Harvard, Cancer Research, JAMA, Lancet, Lung Cancer, Medical Imaging, Technology

We demonstrated that the final AI algorithms can actually improve human performance in a human-AI partnership that can result in a direct benefit to patients through greater consistency in segmenting tumors and accelerating times to treatment.

Samir Parekh, MBBS Hematology-Oncology, Cancer Director of Translational Research in Myeloma and Co-leader of the Cancer Clinical Investigation program The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai

06 Sep T-Cell Sequencing May Allow Relapsed Multiple Myeloma Patients to Respond to Further Therapies

Posted at 15:27h in Author Interviews, Cancer Research, JAMA

MedicalResearch.com Interview with: Samir Parekh, MBBS Hematology-Oncology, Cancer Director of Translational Research in Myeloma and Co-leader of the Cancer Clinical...

02 Sep What is Meth Mouth?

Posted at 14:02h in Addiction, Author Interviews, Methamphetamine

Methamphetamine is a highly addictive stimulant drug that is often used recreationally. It is a central nervous system (CNS) stimulant...

Robert Wild, Ph.D Chief Scientific Officer Dracen Pharmaceuticals

20 May Glutamine Antagonist Sirpiglenastat (DRP-104) Has Therapeutic Potential in Targeting Lung Cancer, SCCHN, and Prostate Cancer

Posted at 10:39h in Author Interviews, Cancer Research, Pharmaceutical Companies

DRP-104 has significant promise with multiple paths to registration including potential for accelerated approval as a single agent and in combination with various immune modulating therapies

Left: Mario Gaudino, MD PhD; Right: Antonino Di Franco, MD

06 Apr Coronary Artery Disease: Women Have Worse Outcomes Following Both Medical and Invasive Treatments

Posted at 21:31h in Author Interviews, Gender Differences, Heart Disease, JACC, Surgical Research

Addressing sex-related disparities in treatment and access to care is an important target for reducing the global burden of CAD.

"Blood Pressure Bulb Block Integrative Cancer Medical Center 12-2-14" by Steven Depolo is licensed under CC BY 2.0

07 Mar Oral Bacteria May Be Linked to Hypertension Risk in Post-Menopausal Women

Posted at 21:26h in AHA Journals, Blood Pressure - Hypertension, Dental Research, Menopause

MedicalResearch.com Interview with: Michael J. LaMonte, PhD, MPH Research Professor (epidemiology) Department of Epidemiology and Environmental Health School of Public...

Andrea B. Troxel, ScD (she/her/hers) Professor and Director, Division of Biostatistics Department of Population Health NYU Grossman School of Medicine NYU Langone Health

03 Feb COVID-19: Study Finds Narrow Window For Convalescent Plasma Effectiveness

Posted at 18:32h in Author Interviews, COVID -19 Coronavirus, JAMA, NYU

If patients are already hospitalized and severely ill, as in our study, it may be too late for convalescent plasma to work.

24 Jan The CD6/ALCAM Pathway Promotes Lupus Nephritis via T cell–Mediated Responses

Posted at 13:23h in Author Interviews, Kidney Disease, Rheumatology

Pathogenic T cells are instrumental in the development and progression of both SLE and Lupus Nephritis.

08 Dec GenXys is Taking the Guesswork out of Prescribing Medications: Is Your Practice Ready for personalized medicine for everyone?

Posted at 23:17h in Author Interviews, Electronic Records, Pharmacology

The good news is that modern technology can help the clinicians with accurate prescribing choices.

Leonard B. Bacharier, MD Janie Robinson and John Moore Lee Chair in Pediatrics Professor of Pediatrics Director - Center for Pediatric Asthma Research Scientific Director - Center for Clinical and Translational Research Section Chief - Pediatric Allergy and Immunology Division of Allergy, Immunology and Pulmonary Medicine

08 Dec NEJM: Dupilumab for Pediatric Uncontrolled Moderate-to-Severe Asthma

Posted at 22:07h in Asthma, Author Interviews, NEJM, Pediatrics, Pulmonary Disease, Vanderbilt

This is the first study to demonstrate that, in children 6-11 years of age, the addition of a biologic( dupilumab) led to improvements in both exacerbations and lung function with an acceptable safety profile.

30 Nov 3 Top Ophthalmological Advances for 2021

Posted at 20:42h in Author Interviews

Concerning laser vision correction, it is used simultaneously with additional tests to decide on the amount of corneal tissue to be extracted for vision correction. Corneal topography is an effective tool in evaluating corneal abrasions, diseases, deformities, and other corneal issues.

social-isolation-quarantine-work-from-home

30 Nov The Impact of Social Isolation on Mental Health

Posted at 17:16h in Mental Health Research

There is a much greater need to increase the number of mental health services and also improve the diversity and depth of the professional mental health community.

Bruno Caramelli MD PhD Associate Professor of Medicine University of Sao Paulo, Brasil Director, Interdisciplinary Medicine in Cardiology Unit Chairman of the PhD program in Medical Sciences at the University of Sao Paulo, Brazil. President of the Department of Clinical Cardiology at the Brazilian Society of Cardiology FESC: Fellow of the European Society of Cardiology

23 Nov AHA21: GIRAF Study Results Comparing Anticoagulants and Cognitive Decline in AFib Patients

Posted at 00:24h in Alzheimer's - Dementia, Author Interviews, Clots - Coagulation, Heart Disease

GIRAF study suggests that for the preservation of cognitive function in patients with atrial fibrillation, adequate treatment is more important than the choice of the drug for anticoagulation.

Brianna M. Jones, MD Radiation Oncology Resident Icahn School of Medicine at Mount Sinai

01 Nov Increased Risk of COVID-19 Deaths and Severe Disease Among Cancer Patients

Posted at 23:22h in Author Interviews, Cancer Research, COVID -19 Coronavirus, Race/Ethnic Diversity, Radiation Therapy

Importantly, there was a disproportionate burden of COVID morbidity and mortality in patients of Hispanic ethnicity and certain insurance types.

27 Oct Risankizumab Found Ineffective in Severe Asthma

Posted at 21:30h in Asthma, Author Interviews, NEJM

Not only was targeting the IL23 pathway in asthma not beneficial those treated with risankizumab had worse outcomes than those treated with placebo.

Andres Zorrilla Vaca, MD Resident Physician Brigham and Women’s Hospital Boston, Massachusetts

21 Sep Surgery: ERAS Protocol Reduced Need for Opioids After Discharge

Posted at 11:20h in Anesthesiology, Author Interviews, Brigham & Women's - Harvard, Opiods, Surgical Research

ERAS is a multidisciplinary evidence-based perioperative care pathway that was originally designed to hasten recovery, but studies like ours give relevant insights to patients regarding the role of ERAS in reducing opioid prescriptions at hospital discharge.

11 Sep Circadian Body Clock Helps Explain Why Asthma Worsens at Night

Posted at 12:42h in Asthma, Author Interviews, Brigham & Women's - Harvard, Circadian Rhythm, Occupational Health, PNAS, Pulmonary Disease, Sleep Disorders

Those people who have the worst asthma in general are the ones who suffer from the greatest circadian-induced drops in pulmonary function at night, and also had the greatest changes induced by behaviors, including sleep.

10 Sep Pronounced Regional Disparities in Methadone Availability in the United States

Posted at 14:33h in Addiction, Author Interviews, Opiods, Race/Ethnic Diversity

Methadone for the treatment of opioid use disorder (OUD) is exclusively provided by federally regulated opioid treatment programs (OTPs) and has provoked significant community-based and legal controversy regarding its role in the management of this condition.

Joy M. Schmitz, Ph.D. Professor and Faillace Chair Director, Center for Neurobehavioral Research on Addiction (CNRA) Faillace Department of Psychiatry and Behavioral Sciences Behavioral and Biomedical Sciences Building (BBSB) Houston, TX 77054

07 Aug New Approach to Addiction: Diabetes Drug May Curb Cravings and Protect Brain White Matter

Posted at 22:03h in Addiction, Author Interviews, Cocaine, Diabetes, Methamphetamine

We think this research points to a new direction in medication development for the treatment of cocaine use disorder, and possibly other stimulants like methamphetamine.